Steward Financial Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $0 | Buy |
+3
| New | – | ﹤0.01% | 1447 |
|
|
2023
Q2 | – | Sell |
-6
| Closed | – | – | 761 |
|
|
2023
Q1 | $0 | Buy |
6
+3
| +100% | – | ﹤0.01% | 827 |
|
|
2022
Q4 | $0 | Buy |
+3
| New | – | ﹤0.01% | 691 |
|
|
2022
Q3 | – | Sell |
-5
| Closed | – | – | 762 |
|
|
2022
Q2 | $0 | Buy |
+5
| New | – | ﹤0.01% | 1187 |
|